|
Volumn 23, Issue 2, 2013, Pages 131-132
|
The LKB1-AMPK Pathway-Friend or Foe in Cancer?
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ADENOSINE DIPHOSPHATE;
ADENOSINE TRIPHOSPHATE;
BIGUANIDE DERIVATIVE;
GLUCOSE;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE;
INSULIN;
METFORMIN;
PHENFORMIN;
PROTEIN KINASE LKB1;
PROTEIN P53;
AEROBIC METABOLISM;
ANIMAL EXPERIMENT;
APOPTOSIS;
CANCER RISK;
CANCER SIZE;
CANCER THERAPY;
CELL DEATH;
DRUG EFFICACY;
DRUG MECHANISM;
GLUCOSE BLOOD LEVEL;
HUMAN;
HYPERGLYCEMIA;
LACTIC ACIDOSIS;
LUNG NON SMALL CELL CANCER;
METABOLIC STRESS;
MOUSE;
NON INSULIN DEPENDENT DIABETES MELLITUS;
NONHUMAN;
OVERALL SURVIVAL;
PRIORITY JOURNAL;
PROTEIN EXPRESSION;
SHORT SURVEY;
TUMOR CELL;
TUMOR GROWTH;
|
EID: 84873608350
PISSN: 15356108
EISSN: 18783686
Source Type: Journal
DOI: 10.1016/j.ccr.2013.01.009 Document Type: Short Survey |
Times cited : (69)
|
References (10)
|